177 related articles for article (PubMed ID: 23396259)
1. Supersaturatable formulations for the enhanced oral absorption of sirolimus.
Kim MS; Kim JS; Cho W; Cha KH; Park HJ; Park J; Hwang SJ
Int J Pharm; 2013 Mar; 445(1-2):108-16. PubMed ID: 23396259
[TBL] [Abstract][Full Text] [Related]
2. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.
Cho Y; Ha ES; Baek IH; Kim MS; Cho CW; Hwang SJ
Molecules; 2015 May; 20(6):9496-509. PubMed ID: 26020699
[TBL] [Abstract][Full Text] [Related]
3. Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles.
Kim MS; Kim JS; Cho WK; Hwang SJ
Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):85-91. PubMed ID: 23305536
[TBL] [Abstract][Full Text] [Related]
4. Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.
Ha ES; Choo GH; Baek IH; Kim JS; Cho W; Jung YS; Jin SE; Hwang SJ; Kim MS
Int J Biol Macromol; 2015 Jan; 72():218-22. PubMed ID: 25159878
[TBL] [Abstract][Full Text] [Related]
5. Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.
Yoshida T; Kurimoto I; Yoshihara K; Umejima H; Ito N; Watanabe S; Sako K; Kikuchi A
Drug Dev Ind Pharm; 2013 Nov; 39(11):1698-705. PubMed ID: 23062024
[TBL] [Abstract][Full Text] [Related]
6. Optimized formulation of solid self-microemulsifying sirolimus delivery systems.
Cho W; Kim MS; Kim JS; Park J; Park HJ; Cha KH; Park JS; Hwang SJ
Int J Nanomedicine; 2013; 8():1673-82. PubMed ID: 23641156
[TBL] [Abstract][Full Text] [Related]
7. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
8. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method.
Solymosi T; Angi R; Basa-Dénes O; Ránky S; Ötvös Z; Glavinas H; Filipcsei G; Heltovics G
Eur J Pharm Biopharm; 2015 Aug; 94():135-40. PubMed ID: 26003815
[TBL] [Abstract][Full Text] [Related]
10. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
11. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
Gao P; Akrami A; Alvarez F; Hu J; Li L; Ma C; Surapaneni S
J Pharm Sci; 2009 Feb; 98(2):516-28. PubMed ID: 18543293
[TBL] [Abstract][Full Text] [Related]
12. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
[TBL] [Abstract][Full Text] [Related]
13. Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique.
Jang SW; Kang MJ
Int J Pharm; 2014 Oct; 473(1-2):187-93. PubMed ID: 25003829
[TBL] [Abstract][Full Text] [Related]
14. Enhanced water solubility, antioxidant activity, and oral absorption of hesperetin by D-α-tocopheryl polyethylene glycol 1000 succinate and phosphatidylcholine.
Gu SF; Wang LY; Tian YJ; Zhou ZX; Tang JB; Liu XR; Jiang HP; Shen YQ
J Zhejiang Univ Sci B; 2019 Mar.; 20(3):273-281. PubMed ID: 30829014
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations.
Gao P; Guyton ME; Huang T; Bauer JM; Stefanski KJ; Lu Q
Drug Dev Ind Pharm; 2004 Feb; 30(2):221-9. PubMed ID: 15089057
[TBL] [Abstract][Full Text] [Related]
17. Establishment of new preparation method for solid dispersion formulation of tacrolimus.
Yamashita K; Nakate T; Okimoto K; Ohike A; Tokunaga Y; Ibuki R; Higaki K; Kimura T
Int J Pharm; 2003 Nov; 267(1-2):79-91. PubMed ID: 14602386
[TBL] [Abstract][Full Text] [Related]
18. Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.
Beak IH; Kim MS
Chem Pharm Bull (Tokyo); 2012; 60(11):1468-73. PubMed ID: 23124571
[TBL] [Abstract][Full Text] [Related]
19. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability.
Chen Y; Chen C; Zheng J; Chen Z; Shi Q; Liu H
Biol Pharm Bull; 2011; 34(2):278-86. PubMed ID: 21415541
[TBL] [Abstract][Full Text] [Related]
20. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Ghosh I; Bose S; Vippagunta R; Harmon F
Int J Pharm; 2011 May; 409(1-2):260-8. PubMed ID: 21371540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
